5.59
price up icon0.90%   0.05
after-market 시간 외 거래: 5.50 -0.09 -1.61%
loading
전일 마감가:
$5.54
열려 있는:
$5.56
하루 거래량:
319.22K
Relative Volume:
0.44
시가총액:
$722.01M
수익:
$58.49M
순이익/손실:
$-105.04M
주가수익비율:
-4.301
EPS:
-1.2997
순현금흐름:
$-13.78M
1주 성능:
+2.38%
1개월 성능:
-6.99%
6개월 성능:
-24.66%
1년 성능:
-53.49%
1일 변동 폭
Value
$5.51
$5.82
1주일 범위
Value
$5.23
$5.82
52주 변동 폭
Value
$3.30
$13.09

Immatics N V Stock (IMTX) Company Profile

Name
명칭
Immatics N V
Name
전화
-
Name
주소
-
Name
직원
423
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
IMTX's Discussions on Twitter

IMTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMTX
Immatics N V
5.59 722.01M 58.49M -105.04M -13.78M -1.2997
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Immatics N V Stock (IMTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-28 개시 Deutsche Bank Buy
2024-10-07 개시 Piper Sandler Overweight
2023-11-02 개시 Cantor Fitzgerald Overweight
2023-03-31 개시 Mizuho Buy
2023-03-24 개시 Bryan Garnier Buy
2020-11-20 개시 BofA Securities Buy
2020-09-22 개시 Goldman Buy
2020-07-27 개시 SVB Leerink Outperform
2020-07-24 개시 Jefferies Buy
모두보기

Immatics N V 주식(IMTX)의 최신 뉴스

pulisher
Jun 18, 2025

Immatics N.V. Shareholders Approve Key Resolutions at June 2025 AGM - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

These Numbers Reveal How Powerful Immatics N.V (NASDAQ: IMTX) Stock Is - Stocksregister

Jun 17, 2025
pulisher
Jun 11, 2025

Learn to Evaluate (IMTX) using the Charts - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on Immatics FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Sells 36,345 Shares of Immatics (NASDAQ:IMTX) - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Immatics (NASDAQ:IMTX) Shares Sold by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - Revista ADVFN

Jun 05, 2025
pulisher
Jun 05, 2025

Immatics rises on data from early stage cell therapy trial - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Has $1.11 Million Holdings in Immatics (NASDAQ:IMTX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Immatics: Taking Off On A PRAME Rocketship - Seeking Alpha

Jun 04, 2025
pulisher
Jun 03, 2025

Does Immatics (IMTX) Have the Potential to Rally 174.54% as Wall Street Analysts Expect? - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Immatics Announces Annual General Meeting for June 2025 - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

immatics n.v. announces upcoming annual general meeting By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

immatics n.v. announces upcoming annual general meeting - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Immatics (IMTX) Soars After Positive Trial Results for Cell Ther - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Cantor Fitzgerald reiterates overweight rating on Immatics stock By Investing.com - Investing.com UK

Jun 02, 2025
pulisher
Jun 02, 2025

Immatics Presents Promising IMA203 Data at ASCO 2025 - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Form 6-K Immatics N.V. For: Jun 02 - StreetInsider

Jun 02, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Purchases 11,304 Shares of Immatics (NASDAQ:IMTX) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Immatics (IMTX) Shares Promising Data from IMA203 Melanoma Trials | IMTX Stock News - GuruFocus

Jun 01, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 - GlobeNewswire

May 31, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma | IMTX Stock News - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Immatics N.V. Reports Promising Long-Term Efficacy and Safety Data from Phase 1b Trial of IMA203 PRAME Cell Therapy in Metastatic Melanoma - Nasdaq

May 31, 2025
pulisher
May 31, 2025

PRAME Cell Therapy Shows 56% Response Rate in Melanoma Patients at ASCO 2025 | IMTX Stock News - Stock Titan

May 31, 2025
pulisher
May 31, 2025

Immatics (NASDAQ:IMTX) Receives $17.00 Average Price Target from Analysts - Defense World

May 31, 2025
pulisher
May 30, 2025

Immatics N.V. (IMTX) Stock Analysis: Uncovering a 163% Upside Potential in the Biotech Arena - DirectorsTalk Interviews

May 30, 2025
pulisher
May 29, 2025

Long Term Trading Analysis for (IMTX) - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Immatics (NASDAQ:IMTX) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft - Defense World

May 29, 2025
pulisher
May 29, 2025

D. E. Shaw & Co. Inc. Has $176,000 Stake in Immatics (NASDAQ:IMTX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Deutsche Bank Initiates Coverage of Immatics N.V. (IMTX) with Buy Recommendation - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Immatics (IMTX) Receives "Buy" Rating from Deutsche Bank | IMTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank Initiates Coverage on Immatics With Buy Rating, $10 Price Target - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank Gives Immatics (IMTX) a Boost with Buy Rating and $10 Target | IMTX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank sets $10 target for Immatics stock on Buy rating - Investing.com UK

May 28, 2025
pulisher
May 18, 2025

Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World

May 18, 2025
pulisher
May 17, 2025

Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st

May 17, 2025
pulisher
May 16, 2025

The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX) - Defense World

May 16, 2025
pulisher
May 15, 2025

We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance

May 15, 2025
pulisher
May 14, 2025

Immatics: Q1 Earnings Snapshot - CT Insider

May 14, 2025
pulisher
May 14, 2025

Immatics Announces First Quarter 2025 Financial Results and Business Update - GlobeNewswire

May 14, 2025
pulisher
May 13, 2025

Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Immatics NV reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs - TipRanks

May 13, 2025

Immatics N V (IMTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):